To prohibit the expenditure of Federal funds to Amtrak.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
27pct
1d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
This bill prohibits the availability of federal funds to Amtrak.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2015 · second_quarter · Medicare/Medicaid
Graduate medical education funding; Recovery audit contractors; Medicare physician payment - sustainable growth rate formula, H.R. 2 Medicare Acccess and CHIP Re-authorization; Children's Health Insurance Program; Medicare/Medicaid coverage issues, H.R. 605 Home Infusion Site of Care Act; Durable medical equipment competitive bidding, H.R. 2021 Protecting the Integrity of Medicare Act; Hospital readmissions policy, S.688/H.R. 1343 Establishing Beneficiary Equity in the Hospital Readmission Program Act; CMS Innovation Grants
Client expense: $120,000 · Firm income: Not reported
Referred to the Subcommittee on Railroads, Pipelines, and Hazardous Materials.
Referred to the House Committee on Transportation and Infrastructure.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Medicare/Medicaid
Graduate medical education funding; Recovery audit contractors; Medicare physician payment - sustainable growth rate formula, H.R. 2 Medicare Acccess and CHIP Re-authorization; Children's Health Insurance Program; Medicare/Medicaid coverage issues, H.R. 605 Home Infusion Site of Care Act; Durable medical equipment competitive bidding, H.R. 2021 Protecting the Integrity of Medicare Act; Hospital readmissions policy, S.688/H.R. 1343 Establishing Beneficiary Equity in the Hospital Readmission Program Act; Reimbursement policy of pharmacy services, H.R. 592 Pharmacy and Medically Underserved Areas Enchancement Act; Innovation Grants
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE